Effect of physician gender on the prescription of estrogen replacement therapy

Journal of General Internal Medicine

Volumn 11, Issue 4, 1996, Pages 197-203

  Seto, Todd B ^a,b   Taira, Deborah A ^b   Davis, Roger B ^b   Safran, Charles ^b   Phillips, Russell S ^b  

^a Hlth Serv Research and Development   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

estrogen replacement therapy; menopause; patient preferences; physician gender

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; POSTMENOPAUSE; PRESCRIPTION; SEX DIFFERENCE;

EID: 0029979396     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02642475     Document Type: Article

References (50)

1. Booher DL. When and why to consider estrogen therapy. Cleve Clin J Med. 1992;59:345-7.
2. More than hot flushes. Lancet. 1991;338:917-8.
3. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163:1438-44.
4. Weinstein MC, Tosteson ANA. Cost-effectiveness of hormone replacement. Ann NY Acad Sci. 1990;592:162-72.
5. Cheung AP, Wren BG. A cost-effectiveness analysis of hormone replacement therapy in the menopause. Med J Aust. 1992;156:312-6.
6. Zubialde JP, Lawler F, Clemenson N. Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis. J Fam Pract. 1993;36:271-80.
7. Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med. 1992;326:1406-16.
8. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325: 756-62.
9. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol. 1986;154:1181-6.
10. Bush TL, Barrett-Conner E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-9.
11. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-37.
12. Falkeborn M, Persson I, Adami HO, et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progesterone replacement. Br J Obstet Gynaecol. 1992;99:821-8.
13. Session DR, Kelly AC, Jewelwicz R. Current concepts in estrogen replacement therapy in the menopause. Fertil Steril. 1993;59: 277-84.
14. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985;313:1038-43.
15. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Arch Intern Med. 1993;153:73-9.
16. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergstrom R. Hormone replacement therapy and the risk of stroke. Arch Intern Med. 1993;153:1201-9.
17. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol. 1992;79:286-94.
18. Henrich JB. The postmenopausal estrogen/breast cancer controversy. JAMA. 1992;268:1900-2.
19. Colditz GA, Egan KE, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol. 1993;168:1473-80.
20. DiSaia PJ. Hormone-replacement therapy in patients with breast cancer. A reappraisal. Cancer. 1993;71:1490-1500.
21. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-93.
22. Brinton LA, Hoover RN. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstet Gynecol. 1993; 81:265-71.
23. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet. 1991;338:274-7.
24. Creasman WT. Estrogen replacement therapy: Is previously treated cancer a contraindication? Obstet Gynecol. 1991;77:308-12.
25. Elstein AS, Holzman GB, Ravitch MM, et al. Comparison of physicians' decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model. Am J Med. 1986;80:246-58.
26. Greendale GA, Carlson KJ, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. J Gen Intern Med. 1990;5:464-9.
27. Schwartz JS, Lewis CE, Clancy C, Kinosian MS, Radany MH, Koplan JP. Internists' practices in health promotion and disease prevention. Ann Intern Med. 1991;114:46-53.
28. Franks P, Clancy CM. Physician gender bias in clinical decision making: screening for cancer in primary care. Med Care. 1993; 31:213-8.
29. Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women. Does the sex of the physician matter? N Engl J Med. 1993;329:478-82.
30. Hall JA, Palmer RH, Orav EJ, Hargraves JL, Wright EA, Louis TA. Performance quality, gender, and professional role. A study of physicians and nonphysicians in 16 ambulatory care practices. Med Care. 1990;28:489-501.
31. Osborn EH, Bird JA, McPhee SJ, Rodnick JE, Fordham D. Cancer screening by primary care physicians. Can we explain the differences? J Fam Pract. 1991;32:465-71.
32. Kreuter MW, Strecher VJ, Harris R, Kobrin SC, Skinner CS. Are patients of women physicians screened more aggressively? A prospective study of physician gender and screening. J Gen Intern Med. 1995;10:119-25.
33. Safran C, Rury C, Rind DM, Taylor WC. A computer based outpatient medical record for a teaching hospital. MD Comput. 1991; 8:291-9.
34. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-37.
35. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-30.
36. Majeroni BA, Karuza J, Wade C, McCreadie M, Calkins E. Gender of physicians and patients and preventive care for community-based older adults. J Am Board Fam Pract. 1993;6:359-65.
37. Lurie N, Margolis K. Physician gender and screening. J Gen Intern Med. 1995;10:171-2.
38. Nichols S. Women's preferences for sex of doctor: a postal survey. J R Coll Gen Pract. 1987;37:540-3.
39. Fennema K, Meyer DL, Owen N. Sex of physician: patients' preferences and stereotypes. J Family Pract. 1990;30:441-6.
40. Livingstone WW, Healy JM, Jordan HS, Warner CK, Zazzali JL. Assessing the needs of women and clinicians for the management of menopause in an HMO. J Gen Intern Med. 1994;9:385-9.
41. Heaton CJ, Marquez JT. Patient preferences for physician gender in the male genital/rectal exam. Fam Pract Res J. 1990;10:105-15.
42. Ackerman-Ross FS, Sochat N. Close encounters of the medical kind: attitudes toward male or female physicians. Soc Sci Med. 1980;14A:61-4.
43. Zare N, Sorenson JR, Heeren T. Sex of provider as a variable in effective genetic counseling. Soc Sci Med. 1984;19:671-5.
44. Cooke M, Ronalds C. Women doctors in urban general practice: the doctors. BMJ. 1985;290:755-8.
45. Roter D, Lipkin M, Korsgaard A. Sex differences in patients' and physicians' communication during primary care visits. Med Care. 1991;29:1083-93.
46. Bensing JM, van den Brink-Muinen A, DeBakker DH. Gender differences in practice style: a Dutch study of general practitioners. Med Care. 1993;31:219-29.
47. Keane D, Woodward CA, Ferner BM, Cohen M, Goldsmith CH. Female and male physicians. Can Fam Physician. 1991;37:72-81.
48. Maheux B, Dufort F, Beland F, Jacques A, Levesque A. Female medical practitioners. More preventive and patient oriented? Med Care. 1990;28:87-92.
49. Morabia A, Fabre J, Dunand JP. The influence of patient and physician gender on prescription of psychotropic drugs. J Clin Epidemiol. 1992;45:111-6.
50. Davidson W, Molloy W, Somers G, Bedard M. Relation between physician characteristics and prescribing for elderly people in New Brunswick. Can Med Assoc J. 1994;150:917-21.